Dermapharm Holding SE (DMPHF PINK) stock market data APIs
$39.2354
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
Dermapharm Holding SE Financial Data Overview
Price chart is built with
Anychart
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Prev. Close
39.2354
Open
39.2354
High
39.2354
Low
39.2354
52 wk Range
37.5639-42.684
Market Cap
2 148 M
P/E Ratio
17.9005
Shares Outstanding
53 840 K
Revenue
1 191 M
Dividends (Yield)
0.0228
Beta
1.272
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dermapharm Holding SE data using free add-ons & libraries
Get Dermapharm Holding SE Fundamental Data
Dermapharm Holding SE Fundamental data includes:
- Net Revenue: 1 191 M
- EBITDA: 257 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dermapharm Holding SE News
New
Will Improving Profitability Despite Lower Sales Change Dermapharm Holding’s (XTRA:DMP) Investment Narrative?
Dermapharm Holding SE recently released earnings for the second quarter and first half of 2025, reporting sales of €275.48 million for the quarter and €580.75 million for the half-year, both sligh...
A Closer Look At Dermapharm Holding SE's (ETR:DMP) Impressive ROE
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). To keep the lesso...
Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.90 Per Share
View Comments
Dermapharm Holding (ETR:DMP) Could Be A Buy For Its Upcoming Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Dermapharm Holding SE (ETR:DMP) is about to go ex-dividend i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
